Cita APA

Yap, T. A., Vieito Villar, M., Sepúlveda, J. M., Kondo, S., Simonelli, M., & Baldini, C. (2021). First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer.

Citación estilo Chicago

Yap, Timothy A., Maria Vieito Villar, Juan Manuel Sepúlveda, Shunsuke Kondo, Matteo Simonelli, y Capucine Baldini. First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients With Advanced Cancer. 2021.

Cita MLA

Yap, Timothy A., et al. First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients With Advanced Cancer. 2021.